These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Hereditary Transthyretin Amyloidosis- Clinical and Genetic Characteristics of a Multiracial South-East Asian Cohort in Singapore. Chen Z; Koh JS; Saini M; Tay KSS; Jayne Tan Y; Chai JYH; Fam SR; Juraidah AR; Lim PK; Ng ASL; Prasad K; Tan CB; Umapathi T; Verma KK; Yong MH; Yu C; Ng PS J Neuromuscul Dis; 2021; 8(4):723-733. PubMed ID: 34024775 [TBL] [Abstract][Full Text] [Related]
9. A case of transthyretin-related cerebral amyloid angiopathy. The other side of hereditary transthyretin amyloidosis. Lemarchant B; Lebouvier T; Delbeuck X; Gibier JB; Tard C Acta Neurol Belg; 2022 Apr; 122(2):571-573. PubMed ID: 35040071 [TBL] [Abstract][Full Text] [Related]
10. Late-onset hereditary ATTR V30M amyloidosis with polyneuropathy: Characterization of Brazilian subjects from the THAOS registry. Pinto MV; Pinto LF; Dias M; Rosa RS; Mundayat R; Pedrosa RC; Waddington-Cruz M J Neurol Sci; 2019 Aug; 403():1-6. PubMed ID: 31163298 [TBL] [Abstract][Full Text] [Related]
11. Ophthalmological manifestations in hereditary transthyretin (ATTR V30M) carriers: a review of 513 cases. Beirão JM; Malheiro J; Lemos C; Beirão I; Costa P; Torres P Amyloid; 2015; 22(2):117-22. PubMed ID: 26096568 [TBL] [Abstract][Full Text] [Related]
12. Genetic and clinical characteristics of hereditary transthyretin amyloidosis in endemic and non-endemic areas: experience from a single-referral center in Japan. Yamashita T; Ueda M; Misumi Y; Masuda T; Nomura T; Tasaki M; Takamatsu K; Sasada K; Obayashi K; Matsui H; Ando Y J Neurol; 2018 Jan; 265(1):134-140. PubMed ID: 29177547 [TBL] [Abstract][Full Text] [Related]
13. Imaging of amyloid burden and distribution in cerebral amyloid angiopathy. Johnson KA; Gregas M; Becker JA; Kinnecom C; Salat DH; Moran EK; Smith EE; Rosand J; Rentz DM; Klunk WE; Mathis CA; Price JC; Dekosky ST; Fischman AJ; Greenberg SM Ann Neurol; 2007 Sep; 62(3):229-34. PubMed ID: 17683091 [TBL] [Abstract][Full Text] [Related]
16. 11C-PIB binding is increased in patients with cerebral amyloid angiopathy-related hemorrhage. Ly JV; Donnan GA; Villemagne VL; Zavala JA; Ma H; O'Keefe G; Gong SJ; Gunawan RM; Saunder T; Ackerman U; Tochon-Danguy H; Churilov L; Phan TG; Rowe CC Neurology; 2010 Feb; 74(6):487-93. PubMed ID: 20142615 [TBL] [Abstract][Full Text] [Related]
17. Diagnostic Utility of Integrated Chang Y; Liu J; Wang L; Li X; Wang Z; Lin M; Jin W; Zhu M; Xu B Front Aging Neurosci; 2021; 13():721780. PubMed ID: 34899265 [No Abstract] [Full Text] [Related]
18. CSF/plasma levels, transthyretin stabilisation and safety of multiple doses of tolcapone in subjects with hereditary ATTR amyloidosis. Takahashi Y; Ohashi N; Takasone K; Yoshinaga T; Yazaki M; Roberts M; Glidden PF; Sekijima Y Amyloid; 2022 Sep; 29(3):190-196. PubMed ID: 35352593 [TBL] [Abstract][Full Text] [Related]
19. Diagnostic utility of amyloid PET in cerebral amyloid angiopathy-related symptomatic intracerebral hemorrhage. Baron JC; Farid K; Dolan E; Turc G; Marrapu ST; O'Brien E; Aigbirhio FI; Fryer TD; Menon DK; Warburton EA; Hong YT J Cereb Blood Flow Metab; 2014 May; 34(5):753-8. PubMed ID: 24619277 [TBL] [Abstract][Full Text] [Related]
20. Amyloid imaging of dutch-type hereditary cerebral amyloid angiopathy carriers. Schultz AP; Kloet RW; Sohrabi HR; van der Weerd L; van Rooden S; Wermer MJH; Moursel LG; Yaqub M; van Berckel BNM; Chatterjee P; Gardener SL; Taddei K; Fagan AM; Benzinger TL; Morris JC; Sperling R; Johnson K; Bateman RJ; ; Gurol ME; van Buchem MA; Martins R; Chhatwal JP; Greenberg SM Ann Neurol; 2019 Oct; 86(4):616-625. PubMed ID: 31361916 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]